Leukaemia cells with the BIM variation under a microscope (IMAGE)

Duke-NUS Medical School

Leukaemia cells with the BIM variation under a microscope

Caption

Leukaemia cells with the BIM variation under a microscope. Such cells often don’t respond well to imatinib, a common type of drug used to treat the disease, but when an MCL-1 inhibitor is added, treatment is more effective with more cancer cells being killed.

Credit

Credit: Duke-NUS Medical School

Usage Restrictions

Credit: Duke-NUS Medical School

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.